EU H2020 Hyperdiamond
HYPERDIAMOND ("Molecular Imaging via Hyperpolarized Nanodiamonds") is a European collaborative research and innovation project. It involves 10 partners from three EU member states (Germany, France, Austria) and EU Associated Countries Israel and Switzerland and includes 3 SME’s, and is led by a multi-disciplinary consortium coordinated by Ulm University.
The objective of HYPERDIAMOND is the development of two new molecular imaging technologies for MRI medical imaging enabling sensitive diagnosis and treatment monitoring based on novel quantum and nanotechnology.
HYPERDIAMOND is supported by the European Commission under the HORIZON 2020 European Union funding for Research and Innovation, Grant Agreement number 667192. With a project budget of 5M€ the project is implemented during 4 years (2016-2019).